Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease Zager RAClin J Am Soc Nephrol 2006[Sep]; 1 Suppl 1 (ä): S24-31Ferric iron (Fe)-carbohydrate complexes are widely used for treating Fe deficiency in patients who are unable to meet their Fe requirements with oral supplements. Intravenous Fe generally is well tolerated and effective in correcting Fe-deficient states. However, the complexing of Fe to carbohydrate polymers does not block its potent pro-oxidant effects; systemic free radical generation and, possibly, tissue damage may result. The purpose of this review is to (1) underscore the capacity of currently used parenteral Fe formulations to induce oxidative stress, (2) compare the severity of these oxidant reactions with those that result from unshielded Fe salts and with each other, and (3) speculate as to the potential of these agents to induce acute renal cell injury and augment systemic inflammatory responses. The experimental data that are reviewed should not be extrapolated to the clinical setting or be used for clinical decision making. Rather, it is hoped that the information provided herein may have utility for clinical hypothesis generation and, hence, future clinical studies. By so doing, a better understanding of Fe's potential protean effects on patients with renal disease may result.|*Renal Dialysis[MESH]|Acute Kidney Injury/*chemically induced/metabolism[MESH]|Adenosine Triphosphate/metabolism[MESH]|Anemia, Iron-Deficiency/*drug therapy/etiology/metabolism[MESH]|Animals[MESH]|Endothelial Cells/drug effects/metabolism[MESH]|Ferric Compounds/toxicity[MESH]|Ferric Oxide, Saccharated[MESH]|Glucaric Acid[MESH]|Hematinics/administration & dosage/*toxicity[MESH]|Humans[MESH]|Inflammation/*chemically induced/metabolism[MESH]|Infusions, Intravenous[MESH]|Iron Compounds/administration & dosage/*toxicity[MESH]|Iron-Dextran Complex/toxicity[MESH]|Kidney Cortex/drug effects/metabolism[MESH]|Kidney Tubules, Proximal/drug effects/metabolism[MESH]|Lipid Peroxidation/drug effects[MESH]|Mitochondria/drug effects/metabolism[MESH]|Oxidative Stress/*drug effects[MESH]|Renal Insufficiency, Chronic/*complications/drug therapy/metabolism/therapy[MESH]|Tumor Necrosis Factor-alpha/metabolism[MESH] |